|
SF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.46724862762449E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.50749976338227E-10 |
| Normal-vs-Stage2 |
3.55389999999733E-05 |
| Normal-vs-Stage3 |
4.75790518095209E-11 |
| Normal-vs-Stage4 |
1.70739999916236E-09 |
| Stage1-vs-Stage2 |
9.623400E-01 |
| Stage1-vs-Stage3 |
1.020360E-01 |
| Stage1-vs-Stage4 |
3.654200E-02 |
| Stage2-vs-Stage3 |
3.083400E-01 |
| Stage2-vs-Stage4 |
1.384210E-01 |
| Stage3-vs-Stage4 |
4.082600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01170199890066E-12 |
| Normal-vs-AfricanAmerican |
2.537600E-03 |
| Normal-vs-Asian |
2.591800E-04 |
| Caucasian-vs-AfricanAmerican |
2.649600E-01 |
| Caucasian-vs-Asian |
3.084200E-02 |
| AfricanAmerican-vs-Asian |
6.575200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.93427521064405E-12 |
| Normal-vs-Female |
5.42570433026413E-11 |
| Male-vs-Female |
7.125600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.62940000065271E-08 |
| Normal-vs-Age(41-60Yrs) |
1.65400004803473E-09 |
| Normal-vs-Age(61-80Yrs) |
2.27949992215315E-10 |
| Normal-vs-Age(81-100Yrs) |
7.036800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.952200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.804100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.483600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.942800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.232400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.933200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.99770000003974E-07 |
| Classical-VS-Follicular |
9.731500E-02 |
| Classical-VS-Other |
1.076990E-01 |
| Classical-VS-Normal |
3.49589999948385E-07 |
| Tall-VS-Follicular |
2.682400E-02 |
| Tall-VS-Other |
8.159200E-01 |
| Tall-VS-Normal |
3.32156524507354E-12 |
| Follicular-VS-Other |
5.344600E-01 |
| Follicular-VS-Normal |
1.05090000035446E-07 |
| Other-VS-Normal |
1.463920E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51519996549609E-09 |
| Normal-vs-N1 |
4.75810000288845E-08 |
| N0-vs-N1 |
2.249200E-01 |
|
|
